David Wise

Accelerating development of first-in-class therapeutics for unmet medical needs

Accelerating development of first-in-class therapeutics for unmet medical needs

Accelerating development of first-in-class therapeutics for unmet medical needs

Accelerating development of first-in-class therapeutics for unmet medical needs

The Maryland Momentum Fund (MMF) was established to invest in promising early-stage companies associated with the University System of Maryland (USM). The fund is focused on companies raising “late seed” rounds, where investments will fill grant and early stage funding gaps in anticipation of a series A round within 18 to 24 months. Founded by the USM Board of Regents with the objective to promote the economic development initiatives of the state, Momentum will give particular attention to developing the innovation ecosystem in key sectors of regional and USM institutional strength. Investments will generally range from $150,000 to $500,000, with $250,000 being the most likely sum, in the form of convertible notes or equity purchases. In all cases, an investment matching (1:1) Momentum funding must be obtained within 6 months. A Maryland-based company is eligible if intellectual property is owned by a USM institution, the principal founder or inventor is a USM faculty, graduate, or student, or if the company is located at a USM research park, incubator, or RISE Zone. Applications are evaluated on an ongoing basis. Eligible companies may notify the Momentum Fund of its intention to seek funding or request a meeting at any time via email. Notices of intent may be sent to Fund Director, David W. Wise, at dwise@umaryland.edu. The review process will also require the company to create a GUST profile. Applicants who are not accepted may be held on active status and receive coaching from Momentum or USM staff to prepare the company for future consideration. Please visit our website link for a full list of initial required information.

THE ABELL FOUNDATION, INC. is a company based out of 111 SOUTH CALVERT STREET, STE 2300, BALTIMORE, Maryland, United States.